IP Library › Granted Patent US 12,590,334
Granted Patent B2
US 12,590,334 · App. 17/822,793 · Granted Mar 31, 2026

Methods for nucleic acid sequence detection

Inventors: Milos Babic (Vista, CA); Christy Lee Trejo (San Diego, CA); Peter J. Shepard (Carlsbad, CA); Joanne M. Yeakley (Encinitas, CA); Bruce Seligmann (Tucson, AZ)
Assignee: BioSpyder Technologies, Inc.
C12Q1/6886C12Q1/6806C12Q2600/112C12Q2600/156
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,590,334
App. No.
17/822,793
Granted
Mar 31, 2026
Kind
B2
Abstract

Barcoded ligation assay products from individual samples.

Claims (57)

1 . A method for detecting target nucleic acid sequences in samples, wherein a target sequence has a downstream region (DR) and an upstream region (UR), comprising

(a) contacting the samples with a pair of detector oligos (DOs), which pair comprises

a downstream detector oligo (DDO) having a complementary downstream region (DR′) and

a separate upstream detector oligo (UDO) having a complementary upstream region (UR′),

wherein at least one of the DDO or UDO has a second complementary region (DR2′ or UR2′) separated from the DR′ or UR′ by a noncomplementary region (CP1) that does not hybridize to the target nucleic acid, whereby the DR2′ or UR2′ specifically hybridizes to a DR2 or UR2 of the target nucleic acid,

and where at least one of the DDO or UDO has been labeled with a barcode sequence,

thereby allowing the pair of detectors to hybridize specifically to target nucleic acids;

(b) whereby the DR′ and UR′ are ligated if both are specifically hybridized to the DR and UR of a target sequence; and

(c) optionally labeling the ligated detectors with a barcode sequence in a plurality of samples;

whereby the barcoded ligation product indicates the presence of the target sequence and identifies the sample.

2 . The method of claim 1 , wherein step (c) is performed by attaching an oligo having a barcode sequence.

3 . The method of claim 1 , further comprising repeating step (c) with a different plurality of samples.

4 . The method of claim 1 , further comprising the steps of mixing the labeled products of step (b), and dividing the mixed labeled products into sets of different pluralities of samples to perform step (c).

5 . The method of claim 1 , further comprising the step of extending a strand.

6 . The method of claim 1 , wherein

step (c) is performed on one end of the ligated product; and

step (c) is repeated on the other end of the ligated product.

7 . The method of claim 1 , further comprising providing a terminal set of barcoded oligos having an amplification sequence.

8 . The method of claim 1 , wherein the sample is a tissue sample.

9 . The method of claim 1 , wherein the samples are dissociated individual cells.

10 . The method of claim 1 , wherein a sample is a single cell.

11 . The method of claim 1 , wherein the number of different barcode sequences is at least 96.

12 . The method of claim 1 , further comprising the step of

permeabilizing the cell walls, cell membranes, or subcellular structures;

dissociating individual cells;

cross-linking detectors to target sequence; or

eluting the ligation product.

13 . The method of claim 1 , further comprising the step of exposing hybridization complexes to at least one nuclease that degrades single strands but does not significantly degrade double strands.

14 . The method of claim 1 , wherein step (c) is performed by attaching oligos having an amplification sequence or its complement.

15 . A method for detecting target nucleic acid sequences in samples, wherein a target sequence has a downstream region (DR) and an upstream region (UR), comprising

(a) contacting the samples with a pair of detector oligos (DOs), which pair comprises

a downstream detector oligo (DDO) having a complementary downstream region (DR′) and

a separate upstream detector oligo (UDO) having a complementary upstream region (UR′),

wherein at least one of the DDO or UDO has a second complementary region (DR2′ or UR2′) separated from the DR′ or UR′ by a noncomplementary region (CP1) that does not hybridize to the target nucleic acid, whereby the DR2′ or UR2′ specifically hybridizes to a DR2 or UR2 of the target nucleic acid,

and where at least one of the DDO or UDO contains a barcode sequence,

thereby allowing the pair of detectors to hybridize specifically to target nucleic acids;

(b) whereby the DR′ and UR′ are ligated if both are specifically hybridized to the DR and UR of a target sequence; and

(c) optionally labeling the ligated detectors with a barcode sequence in a plurality of samples;

whereby the barcoded ligation product indicates the presence of the target sequence and identifies the sample.

16 . The method of claim 15 , wherein step (c) is performed by attaching an oligo having a barcode sequence.

17 . The method of claim 15 , further comprising repeating step (c) with a different plurality of samples.

18 . The method of claim 15 , further comprising the steps of mixing the labeled products of step (b), and dividing the mixed labeled products into sets of different pluralities of samples to perform step (c).

19 . The method of claim 15 , further comprising the step of extending a strand.

20 . The method of claim 15 , wherein

step (c) is performed on one end of the ligated product; and

step (c) is repeated on the other end of the ligated product.

21 . The method of claim 15 , further comprising providing a terminal set of barcoded oligos having an amplification sequence.

22 . The method of claim 15 , wherein the sample is a tissue sample.

23 . The method of claim 15 , wherein the samples are dissociated individual cells.

24 . The method of claim 15 , wherein a sample is a single cell.

25 . The method of claim 15 , wherein the number of different barcode sequences is at least 96.

26 . The method of claim 15 , further comprising the step of

permeabilizing the cell walls, cell membranes, or subcellular structures;

dissociating individual cells;

cross-linking detectors to target sequence; or eluting the ligation product.

27 . The method of claim 15 , further comprising the step of exposing hybridization complexes to at least one nuclease that degrades single strands but does not significantly degrade double strands.

28 . The method of claim 15 , wherein step (c) is performed by attaching oligos having an amplification sequence or its complement.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 18, 2024
From: BABIC, MILOS; TREJO, CHRISTY LEE; SHEPARD, PETER J.; YEAKLEY, JOANNE M.; SELIGMANN, BRUCE
To: BIOSPYDER TECHNOLOGIES, INC.
Reel/Frame 068320/0463 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 17, 2024
From: BABIC, MILOS; TREJO, CHRISTY LEE; SHEPARD, PETER J.; YEAKLEY, JOANNE M.; SELIGMANN, BRUCE
To: BIOSPYDER TECHNOLOGIES, INC.
Reel/Frame 068012/0045 →
Continuity (11)
Continuation 16865246 · May 1, 2020
Continuation In Part 15387650 · Dec 22, 2016
Continuation In Part PCTUS2016014999 · Jan 26, 2016
Continuation In Part 15954546 · Apr 16, 2018
Continuation In Part 15387650 · Dec 22, 2016
Continuation In Part PCTUS2018024206 · Mar 23, 2018
Continuation In Part 14788670 · Jun 30, 2015
Continuation In Part 15920381 · Mar 13, 2018
Division 14595069 · Jan 12, 2015
Provisional Application 62475796 · Mar 23, 2017
Related Publication 20230313309A1 · Oct 5, 2023
References Cited (8)
US 9856521B2 · Stevens · 2018 [cited by examiner]
US 9938566B2 · Shepard · 2018 [cited by examiner]
US 9957550B2 · Yeakley · 2018 [cited by examiner]
US 10683534B2 · Stevens · 2020 [cited by examiner]
US 10934576B2 · Shepard · 2021 [cited by examiner]
US 11091810B2 · Imler · 2021 [cited by examiner]
US 11434538B2 · Babic · 2022 [cited by examiner]
US 20120252686A1 · Umbarger · 2012 [cited by examiner]